Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2010 (2010), Article ID 654858, 7 pages
http://dx.doi.org/10.1155/2010/654858
Research Article

Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia

1Medical Research Building, Brighton and Sussex Medical School, University of Sussex, Falmer BN1 9PS, UK
2Department of Microbiology and Infection, Brighton and Sussex Hospitals NHS Trust, Eastern Road, Brighton BN2 5BE, UK
3Faculty of Medicine, St Mary's Campus, Imperial College, London W2 1PG, UK
4St Georges Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK

Received 5 November 2009; Accepted 8 February 2010

Academic Editor: Michael M. Tunney

Copyright © 2010 James Price et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Lautenschlager, C. Herzog, and W. Zimmerli, “Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different clinical case definitions,” Clinical Infectious Diseases, vol. 16, no. 4, pp. 567–573, 1993. View at Google Scholar · View at Scopus
  2. V. G. Fowler Jr., L. L. Sanders, D. J. Sexton et al., “Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients,” Clinical Infectious Diseases, vol. 27, no. 3, pp. 478–486, 1998. View at Google Scholar · View at Scopus
  3. V. G. Fowler Jr., M. K. Olsen, G. R. Corey et al., “Clinical identifiers of complicated Staphylococcus aureus bacteremia,” Archives of Internal Medicine, vol. 163, no. 17, pp. 2066–2072, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Ringberg, A. Thorén, and B. Lilja, “Metastatic complications of Staphylococcus aureus septicemia. To seek is to find,” Infection, vol. 28, no. 3, pp. 132–136, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. F.-Y. Chang, J. E. Peacock Jr., D. M. Musher et al., “Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study,” Medicine, vol. 82, no. 5, pp. 333–339, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Peacock, C. E. Moore, A. Justice et al., “Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus,” Infection and Immunity, vol. 70, no. 9, pp. 4987–4996, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Lindsay, C. E. Moore, N. P. Day et al., “Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes,” Journal of Bacteriology, vol. 188, no. 2, pp. 669–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. V. G. Fowler Jr., A. Justice, C. Moore et al., “Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia,” Clinical Infectious Diseases, vol. 40, no. 5, pp. 695–703, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. R. M. Klevens, M. A. Morrison, J. Nadle et al., “Invasive methicillin-resistant Staphylococcus aureus infections in the United States,” Journal of the American Medical Association, vol. 298, no. 15, pp. 1763–1771, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. E. J. Feil, J. E. Cooper, H. Grundmann et al., “How clonal is Staphylococcus aureus?” Journal of Bacteriology, vol. 185, no. 11, pp. 3307–3316, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. D. Cockfield, S. Pathak, J. D. Edgeworth, and J. A. Lindsay, “Rapid determination of hospital-acquired meticillin-resistant Staphylococcus aureus lineages,” Journal of Medical Microbiology, vol. 56, no. 5, pp. 614–619, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Jarraud, C. Mougel, J. Thioulouse et al., “Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease,” Infection and Immunity, vol. 70, no. 2, pp. 631–641, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Becker, R. Roth, and G. Peters, “Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene,” Journal of Clinical Microbiology, vol. 36, no. 9, pp. 2548–2553, 1998. View at Google Scholar · View at Scopus
  14. H.-Y. Tsen and T.-R. Chen, “Use of the polymerase chain reaction for specific detection of type A, D and E enterotoxigenic Staphylococcus aureus in foods,” Applied Microbiology and Biotechnology, vol. 37, no. 5, pp. 685–690, 1992. View at Google Scholar · View at Scopus
  15. R. J. Gordon and F. D. Lowy, “Pathogenesis of methicillin-resistant Staphylococcus aureus infection,” Clinical Infectious Diseases, vol. 46, supplement 5, pp. S350–S359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Lalani, J. J. Federspiel, H. W. Boucher et al., “Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients,” Journal of Clinical Microbiology, vol. 46, no. 9, pp. 2890–2896, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Ganga, K. Riederer, M. Sharma et al., “Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center,” Journal of Clinical Microbiology, vol. 47, no. 3, pp. 590–595, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. E. Waldron and J. A. Lindsay, “Sau1: a novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages,” Journal of Bacteriology, vol. 188, no. 15, pp. 5578–5585, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Holtfreter, D. Grumann, M. Schmudde et al., “Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates,” Journal of Clinical Microbiology, vol. 45, no. 8, pp. 2669–2680, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. H. Kollef, “Limitations of vancomycin in the management of resistant staphylococcal infections,” Clinical Infectious Diseases, vol. 45, supplement 3, pp. S191–S195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Das, N. O'Connell, and P. Lambert, “Epidemiology, clinical and laboratory characteristics of Staphylococcus aureus bacteraemia in a university hospital in UK,” Journal of Hospital Infection, vol. 65, no. 2, pp. 117–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Melzer, S. J. Eykyn, W. R. Gransden, and S. Chinn, “Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia,” Clinical Infectious Diseases, vol. 37, no. 11, pp. 1453–1460, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Soriano, F. Marco, J. A. Martinez et al., “Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia,” Clinical Infectious Diseases, vol. 46, no. 2, pp. 193–200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Price, S. Atkinson, M. Llewelyn, and J. Paul, “Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin,” Clinical Infectious Diseases, vol. 48, no. 7, pp. 997–998, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. L. Sullenberger, L. S. Avedissian, and S. M. Kent, “Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia,” Journal of Heart Valve Disease, vol. 14, no. 1, pp. 23–28, 2005. View at Google Scholar · View at Scopus
  26. P. C. Hill, M. Birch, S. Chambers et al., “Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality,” Internal Medicine Journal, vol. 31, no. 2, pp. 97–103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. L. E. Wilson, D. L. Thomas, J. Astemborski, T. L. Freedman, and D. Vlahov, “Prospective study of infective endocarditis among injection drug users,” Journal of Infectious Diseases, vol. 185, no. 12, pp. 1761–1766, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. J. M. Mylotte and A. Tayara, “Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort,” Clinical Infectious Diseases, vol. 31, no. 5, pp. 1170–1174, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Cooper and R. Platt, “Staphylococcus aureus bacteremia in diabetic patients. Endocarditis and mortality,” American Journal of Medicine, vol. 73, no. 5, pp. 658–662, 1982. View at Google Scholar · View at Scopus